References
- MacleanJRPfisterMZhouZQuantifying the impact of non-adherence patterns on exposure to oral immunosuppressantsTher Clin Risk Manag2011714915621691585
- MorrisonAStaufferMEKaufmanASDefining medication adherence in individual patientsPatient Prefer Adherence2015989389726170639
- GreeneGCostelloRWCushenBA novel statistical method for assessing effective adherence to medication and calculating optimal drug dosagesPLoS One2018134e019566329677197
- ParientiJJDas-DouglasMMassariVNot all missed doses are the same: sustained NNRTI treatment interruptions predict HIV rebound at low-to-moderate adherence levelsPLoS One200837e278318665246
- OsterbergLGUrquhartJBlaschkeTFUnderstanding forgiveness: minding and mining the gaps between pharmacokinetics and therapeuticsClin Pharmacol Ther201088445745920856243
- MorrisonAStaufferMEKaufmanASRelationship Between Adherence Rate Threshold and Drug ‘Forgiveness’Clin Pharmacokinet201756121435144028470545
- TuWNyandikoWMLiuHPharmacokinetics-based adherence measures for antiretroviral therapy in HIV-infected Kenyan childrenJ Int AIDS Soc20172012115728605170
- DickinsonLBoffitoMKhooSHPharmacokinetic analysis to assess forgiveness of boosted saquinavir regimens for missed or late dosingJ Antimicrob Chemother200862116116718467305
- ValadeETréluyerJMBouazzaNPopulation pharmacokinetics of emtricitabine in HIV-1-infected adult patientsAntimicrob Agents Chemother20145842256226124492366
- ChaturvedulaAFosslerMJHendrixCWEstimation of tenofovir’s population pharmacokinetic parameters without reliable dosing histories and application to tracing dosing history using simulation strategiesJ Clin Pharmacol201454215016024203458
- Ouwerkerk-MahadevanSBeumont-MauvielMMortierSEvaluation of the pharmacokinetics and renal excretion of simeprevir in subjects with renal impairmentDrugs R D201515326127026248593
- VrijensBVinczeGKristantoPUrquhartJBurnierMAdherence to prescribed antihypertensive drug treatments: longitudinal study of electronically compiled dosing historiesBMJ200833676531114111718480115
- OsterbergLBlaschkeTAdherence to medicationN Engl J Med2005353548749716079372
- StaufferMEHutsonPKaufmanASMorrisonAThe adherence rate threshold is drug specificDrugs R D201717464565329076037
- HabererJEMusinguziNBoumYDuration of antiretroviral therapy adherence interruption is associated with risk of virologic rebound as determined by real-time adherence monitoring in rural UgandaJ Acquir Immune Defic Syndr201570438639226110445
- GenbergBLWilsonIBBangsbergDRPatterns of antiretroviral therapy adherence and impact on HIV RNA among patients in North AmericaAIDS201226111415142322767342
- KnobelHUrbinaOGonzálezAImpact of different patterns of nonadherence on the outcome of highly active antiretroviral therapy in patients with long-term follow-upHIV Med200910636436919490179
- GishRGLeungNWWrightTLDose range study of pharmacokinetics, safety, and preliminary antiviral activity of emtricitabine in adults with hepatitis B virus infectionAntimicrob Agents Chemother20024661734174012019083
- RibaudoHJHaasDWTierneyCPharmacogenetics of plasma efavirenz exposure after treatment discontinuation: an adult AIDS Clinical Trials Group studyClin Infect Dis200642340140716392089
- HarrisRAHabererJEMusinguziNPredicting short-term interruptions of antiretroviral therapy from summary adherence data: development and test of A probability modelPLoS One2018133e019471329566096